secwatch.observer — SEC 8-K summary
======================================

Issuer:     Akoya Biosciences, Inc. (—)
CIK:        0001711933
Form:       8-K
Filed at:   2023-09-06T23:59:59+00:00
Accession:  0001104659-23-098637
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Akoya Biosciences amends bylaws to adopt Universal Proxy Rules and DGCL updates
-------------------------------------------------------------------------------

- Enhanced disclosure requirements for stockholder director nominations and other proposals.
- Requires stockholders to represent intent to solicit proxies under Rule 14a-19 for non-company nominees.
- Company will disregard nominations if stockholder fails to comply with Rule 14a-19 requirements.
- Prohibits placeholder nominees; white proxy card reserved exclusively for the Board.
- Updates stockholder list provisions to reflect recent Delaware General Corporation Law amendments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711933/000110465923098637/0001104659-23-098637-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711933/000110465923098637/tm2325584d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-098637

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer